Abstract:Glucagon-like peptide-1 (GLP-1) is an incretin which is secreted by the distal ileum, colon and rectum L cells, and it also can promote the secretion of insulin.Recent 20 years studies have showed that GLP-1 not only has the effect maintain glucose homeostasis, but also plays an important role in regulating gastrointestinal motility and related gastrointestinal disease.GLP-1 plays a major role in the inhibition of gastrointestinal motility, and its mechanism may be related to the cholinergic vagal and nitric oxide (NO) release.In terms of gastrointestinal diseases, GLP-1 may be involved in the pathogenesis of irritable bowel syndrome (IBS), inflammatory bowel disease (IBD), short bowel syndrome (SBS) and other diseases, and it may play an important role in the treatment.This article reviewed the advanced study on GLP-1 in the function and mechanism of the gastrointestinal tract.

Advanced study on Glucagon-like peptide-1 in the function and mechanism of the gastrointestinal tract